Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

5772

LikeLikedUnlike

Episodes 826-840 of 889

Updates in Glomerular Disease
CME/CE
Updates in Glomerular Disease
- Jürgen Floege, PhD
  Peer
- Jonathan Barratt, PhD
  Peer
- David Jayne, MD
  Peer
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
CME/CE
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
- Danielle Becker, MD, MS, FAES
  Peer
- Ahmed Abdelmoity, MD
  Peer
- Deborah Holder, MD
  Peer
- John Stern, MD
  Peer
Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
CME/CE
Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
- Adam DeVore, MD
  Peer
- Lauren Barron, MD
  Peer
- Navin Kapur, MD
  Peer
Case Management Strategies for Patients with ADPKD – Part 2
CME/CE
Case Management Strategies for Patients with ADPKD – Part 2
- Frederic Rahbari-Oskoui, MD, MSc
  Peer
Case Management Strategies for Patients with ADPKD – Part 1
CME/CE
Case Management Strategies for Patients with ADPKD – Part 1
- Fouad T. Chebib, MD
  Peer
- Pranav S. Garimella, MD
  Peer
Treatment Options for Invasive Fungal Infections: Why They Don't Always Work
CME/CE
Treatment Options for Invasive Fungal Infections: Why They Don't Always Work
- Thomas F. Patterson, MD, FACP, FIDSA
  Peer
- George Thompson III, MD, FIDSA
  Peer
Invasive Fungal Infections: More Common Than You Think
CME/CE
Invasive Fungal Infections: More Common Than You Think
- Peter G. Pappas, MD, FACP
  Peer
- Thomas F. Patterson, MD, FACP, FIDSA
  Peer
Alloimmune Neutropenia of the Fetus and Newborn
CME/CE
Alloimmune Neutropenia of the Fetus and Newborn
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Masja de Haas, MD, PhD
  Peer
Current and Emerging Roles of Immunotherapy and ADCs for Patients with Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
CME/CE
Current and Emerging Roles of Immunotherapy and ADCs for Patients with Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
- Mamta Parikh, MD, MS
  Peer
- Daniel P. Petrylak, MD
  Peer
Current Standards and Future Opportunities for ADCs in Advanced/Metastatic Triple-Negative Breast Cancer
CME/CE
Current Standards and Future Opportunities for ADCs in Advanced/Metastatic Triple-Negative Breast Cancer
- William J. Gradishar, MD
  Peer
- Javier Cortes, MD, PhD
  Peer
- Hope S. Rugo, MD, FASCO
  Peer
Interview with the Investigator
CME/CE
Interview with the Investigator
- Kristen Nowak, PhD
  Peer
Utilization and Management of Antibody-Drug Conjugates in Metastatic Breast Cancer: The Relationship Between ADCs and HER2
CME/CE
Utilization and Management of Antibody-Drug Conjugates in Metastatic Breast Cancer: The Relationship Between ADCs and HER2
- William J. Gradishar, MD
  Peer
- Javier Cortes, MD, PhD
  Peer
- Hope S. Rugo, MD, FASCO
  Peer
A Patient's Journey with ADPKD
CME/CE
A Patient's Journey with ADPKD
Prognostic Tools in the Management of ADPKD
CME/CE
Prognostic Tools in the Management of ADPKD
- Meyeon Park, MD, MAS
  Peer
- Anjay Rastogi, MD, PhD
  Peer
Employing Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
CME/CE
Employing Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
- Robert L. Coleman, MD, FACOG, FACS
  Peer
- Susana Campos, MD, MPH
  Peer
- Domenica Lorusso, MD, PhD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended